BLADDER DYSFUNCTION IN 2016: New insights into interstitial cystitis and chronic pelvic pain syndromes

    loading  Checking for direct PDF access through Ovid

Abstract

In 2016, immunohistochemical evidence revealed major differences in the inflammatory characteristics of Hunner and non-Hunner interstitial cystitis/bladder pain syndrome (IC/BPS). Evidence has also emerged that an isomer of testosterone, etio-S, might be a urinary biomarker of IC/BPS. Intravesical botulinum toxin injections became a standard treatment of IC/BPS. Furthermore, the International Continence Society has published a new Standard for Terminology for Chronic Pelvic Pain Syndromes.

Related Topics

    loading  Loading Related Articles